International Journal of Cancer Management

Published by: Kowsar

Gene Screening of Astrocytoma Grade III Relative to Grade II via Network Analysis: A New Molecular Insight

Mostafa Rezaei-Tavirani 1 , * and Sina Rezaei Tavirani 1
Authors Information
1 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: November 2018, 11 (11); e83201
  • Published Online: November 13, 2018
  • Article Type: Research Article
  • Received: August 12, 2018
  • Revised: October 17, 2018
  • Accepted: October 21, 2018
  • DOI: 10.5812/ijcm.83201

To Cite: Rezaei-Tavirani M , Rezaei Tavirani S. Gene Screening of Astrocytoma Grade III Relative to Grade II via Network Analysis: A New Molecular Insight, Int J Cancer Manag. 2018 ; 11(11):e83201. doi: 10.5812/ijcm.83201.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Wang J, Bettegowda C. Genomic discoveries in adult astrocytoma. Curr Opin Genet Dev. 2015;30:17-24. doi: 10.1016/j.gde.2014.12.002. [PubMed: 25616158]. [PubMed Central: PMC4859210].
  • 2. Jones DT, Mulholland SA, Pearson DM, Malley DS, Openshaw SW, Lambert SR, et al. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts. Acta Neuropathol. 2011;121(6):753-61. doi: 10.1007/s00401-011-0810-6. [PubMed: 21327941].
  • 3. Narsia N, Ramagiri P, Ehrmann J, Kolar Z. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161(3):261-71. doi: 10.5507/bp.2017.020. [PubMed: 28452381].
  • 4. Sethi P, Treece J, Pai V, Onweni C, Rahman Z, Singh S. The mystery of multiple masses: A case of anaplastic astrocytoma. Cureus. 2017;9(6). e1384. doi: 10.7759/cureus.1384. [PubMed: 28775924]. [PubMed Central: PMC5522018].
  • 5. Sarica FB, Cekinmez M, Tufan K, Sen O, Onal HC, Mertsoylu H, et al. Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma. Asian J Neurosurg. 2012;7(4):181-90. doi: 10.4103/1793-5482.106650. [PubMed: 23559985]. [PubMed Central: PMC3613640].
  • 6. Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, et al. Survival and low-grade glioma: The emergence of genetic information. Neurosurg Focus. 2015;38(1). E6. doi: 10.3171/2014.10.FOCUS12367. [PubMed: 25552286]. [PubMed Central: PMC4361022].
  • 7. Killela PJ, Pirozzi CJ, Reitman ZJ, Jones S, Rasheed BA, Lipp E, et al. The genetic landscape of anaplastic astrocytoma. Oncotarget. 2014;5(6):1452-7. doi: 10.18632/oncotarget.1505. [PubMed: 24140581]. [PubMed Central: PMC4039223].
  • 8. MacDonald TJ, Pollack IF, Okada H, Bhattacharya S, Lyons-Weiler J. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis. Methods Mol Biol. 2007;377:203-22. doi: 10.1007/978-1-59745-390-5_13. [PubMed: 17634619].
  • 9. Kunkle BW, Yoo C, Roy D. Reverse engineering of modified genes by Bayesian network analysis defines molecular determinants critical to the development of glioblastoma. PLoS One. 2013;8(5). e64140. doi: 10.1371/journal.pone.0064140. [PubMed: 23737970]. [PubMed Central: PMC3667850].
  • 10. Zamanian-Azodi M, Rezaei-Tavirani M, Rahmati-Rad S, Hasanzadeh H, Rezaei Tavirani M, Seyyedi SS. Protein-protein interaction network could reveal the relationship between the breast and colon cancer. Gastroenterol Hepatol Bed Bench. 2015;8(3):215-24. [PubMed: 26328044]. [PubMed Central: PMC4553162].
  • 11. Rezaei Tavirani M, Mansouri V, Rezaei Tavirani S, Hesami Tackallou S, Rostami - Nejad M. Gliosarcoma protein - protein interaction network analysis and gene ontology. Int J Cancer Manag. 2018;11(5). doi: 10.5812/ijcm.65701.
  • 12. Zali H, Rezaei Tavirani M. Meningioma protein-protein interaction network. Arch Iran Med. 2014;17(4):262-72. [PubMed: 24724603].
  • 13. Rezaei Tavirani M, Bashash D, Tajik Rostami F, Rezaei Tavirani S, Nikzamir A, Rezaei Tavirani M, et al. Celiac disease microarray analysis based on System Biology Approach. Gastroenterol Hepatol Bed Bench. 2018;11(3):216-24. [PubMed: 30013745]. [PubMed Central: PMC6040039].
  • 14. Safari-Alighiarloo N, Rezaei-Tavirani M, Taghizadeh M, Tabatabaei SM, Namaki S. Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ. 2016;4. e2775. doi: 10.7717/peerj.2775. [PubMed: 28028462]. [PubMed Central: PMC5183126].
  • 15. Rezaei-Tavirani M, Rezaei-Taviran S, Mansouri M, Rostami-Nejad M, Rezaei-Tavirani M. Protein-protein interaction network analysis for a biomarker panel related to human esophageal adenocarcinoma. Asian Pac J Cancer Prev. 2017;18(12):3357-63. doi: 10.22034/APJCP.2017.18.12.3357. [PubMed: 29286604]. [PubMed Central: PMC5980895].
  • 16. Barabasi AL. Scale-free networks: A decade and beyond. Science. 2009;325(5939):412-3. doi: 10.1126/science.1173299. [PubMed: 19628854].
  • 17. Safari-Alighiarloo N, Taghizadeh M, Rezaei-Tavirani M, Goliaei B, Peyvandi AA. Protein-protein interaction networks (PPI) and complex diseases. Gastroenterol Hepatol Bed Bench. 2014;7(1):17-31. [PubMed: 25436094]. [PubMed Central: PMC4017556].
  • 18. Cassandri M, Smirnov A, Novelli F, Pitolli C, Agostini M, Malewicz M, et al. Zinc-finger proteins in health and disease. Cell Death Discov. 2017;3:17071. doi: 10.1038/cddiscovery.2017.71. [PubMed: 29152378]. [PubMed Central: PMC5683310].
  • 19. Ying H, Xu Z, Chen M, Zhou S, Liang X, Cai X. Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins. Onco Targets Ther. 2018;11:689-702. doi: 10.2147/OTT.S152138. [PubMed: 29440916]. [PubMed Central: PMC5800459].
  • 20. Jen J, Wang YC. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23(1):53. doi: 10.1186/s12929-016-0269-9. [PubMed: 27411336]. [PubMed Central: PMC4944467].
  • 21. Takada F, Vander Woude DL, Tong HQ, Thompson TG, Watkins SC, Kunkel LM, et al. Myozenin: An alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines. Proc Natl Acad Sci U S A. 2001;98(4):1595-600. doi: 10.1073/pnas.041609698. [PubMed: 11171996]. [PubMed Central: PMC29302].
  • 22. Duncan MB, Yang C, Tanjore H, Boyle PM, Keskin D, Sugimoto H, et al. Type XVIII collagen is essential for survival during acute liver injury in mice. Dis Model Mech. 2013;6(4):942-51. doi: 10.1242/dmm.011577. [PubMed: 23580202]. [PubMed Central: PMC3701214].
  • 23. Honma K, Miyata T, Ochiya T. Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells. Cancer Cell Int. 2007;7:12. doi: 10.1186/1475-2867-7-12. [PubMed: 17578585]. [PubMed Central: PMC1925056].
  • 24. Cho C, Jung-Ha H, Willis WD, Goulding EH, Stein P, Xu Z, et al. Protamine 2 deficiency leads to sperm DNA damage and embryo death in mice. Biol Reprod. 2003;69(1):211-7. doi: 10.1095/biolreprod.102.015115. [PubMed: 12620939].
  • 25. Kato T, Lee D, Wu L, Patel P, Young AJ, Wada H, et al. Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma. Int J Oncol. 2016;49(2):448-56. doi: 10.3892/ijo.2016.3566. [PubMed: 27279560].
  • 26. Khanom R, Nguyen CT, Kayamori K, Zhao X, Morita K, Miki Y, et al. Keratin 17 is induced in oral cancer and facilitates tumor growth. PLoS One. 2016;11(8). e0161163. doi: 10.1371/journal.pone.0161163. [PubMed: 27512993]. [PubMed Central: PMC4981360].
  • 27. Ambasta RK, Schreiber JG, Janiszewski M, Busse R, Brandes RP. Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic Biol Med. 2006;41(2):193-201. doi: 10.1016/j.freeradbiomed.2005.12.035. [PubMed: 16814099].
  • 28. Looke M, Maloney MF, Bell SP. Mcm10 regulates DNA replication elongation by stimulating the CMG replicative helicase. Genes Dev. 2017;31(3):291-305. doi: 10.1101/gad.291336.116. [PubMed: 28270517]. [PubMed Central: PMC5358725].
  • 29. Noda D, Itoh S, Watanabe Y, Inamitsu M, Dennler S, Itoh F, et al. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells. Oncogene. 2006;25(41):5591-600. doi: 10.1038/sj.onc.1209571. [PubMed: 16636667].
  • 30. Blayney LM, Lai FA. Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacol Ther. 2009;123(2):151-77. doi: 10.1016/j.pharmthera.2009.03.006. [PubMed: 19345240]. [PubMed Central: PMC2704947].
  • 31. Nguyen TT, Hull S, Roepman R, van den Born LI, Oud MM, de Vrieze E, et al. Missense mutations in the WD40 domain of AHI1 cause non-syndromic retinitis pigmentosa. J Med Genet. 2017;54(9):624-32. doi: 10.1136/jmedgenet-2016-104200. [PubMed: 28442542]. [PubMed Central: PMC5574394].
  • 32. Ho AW, Garg AV, Monin L, Simpson-Abelson MR, Kinner L, Gaffen SL. The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. PLoS One. 2013;8(7). e70168. doi: 10.1371/journal.pone.0070168. [PubMed: 23922952]. [PubMed Central: PMC3726431].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments